Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$322,843
+$8,178 QoQ
Shares Held
2,060
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,089
of 1,603 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elk River Wealth Management LLC holds $12,158,313 across 5 Drug Manufacturers - General names. NVS ranks #5 (2.7% of the industry book) .
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,843 | 2,060 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $314,665 | 2,060 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $284,012 | 2,060 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $264,174 | 2,060 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $249,280 | 2,060 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $229,648 | 2,060 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $200,458 | 2,060 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $236,941 | 2,060 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $219,307 | 2,060 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $199,263 | 2,060 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $207,998 | 2,060 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $209,831 | 2,060 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $207,874 | 2,060 | Shares | Sole | 2023-07-17 | |
| 2020-12-31 | $206,235 | 2,184 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||